Consensus for HER2 alterations testing in non-small-cell lung cancerShengxiang Ren, Fred R. Hirsch, Jianming Ying et al.|ESMO Open|2022Cited by 110
Tumor-immune microenvironment and NRF2 associate with clinical efficacy of PD-1 blockade combined with chemotherapy in lung squamous cell carcinomaJianchun Duan, Zhijie Wang|Cell Reports Medicine|2023Cited by 28